Waukesha, WI, United States of America

Maxim Y Kiselev


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Radiopharmaceuticals: The Contributions of Maxim Y Kiselev

Introduction

Maxim Y Kiselev, based in Waukesha, WI, is a notable inventor whose contributions to the field of radiopharmaceuticals have had significant impacts in medical imaging and cancer diagnostics. With a strong foundation in chemical engineering, Kiselev has focused on developing methods for synthesizing essential compounds used in positron emission tomography (PET) scans, particularly in the creation of 2-fluoro-2-deoxyglucose.

Latest Patents

Kiselev holds a patent for his innovative method of preparing [.sup.18 F]2-fluoro-2-deoxyglucose. This method utilizes an anion exchange resin in a process that improves the yield of this critical radiopharmaceutical. By conducting an exchange reaction with an aqueous solution of [.sup.18 F]fluoride, along with alkali metal carbonates such as sodium bicarbonate, Kiselev's patented method enhances the efficiency of the production process, enabling better outcomes in clinical applications.

Career Highlights

Maxim Y Kiselev is associated with the General Electric Company, where he has contributed to advancements in medical technologies. His work focuses on optimizing chemical processes that are essential for the production of diagnostic imaging agents. Kiselev's innovations have not only streamlined production but also added value to the field of nuclear medicine.

Collaborations

Throughout his career, Kiselev has collaborated with distinguished colleagues, including Bruce Fletcher Johnson and Johan Ulin. These partnerships have enriched his research endeavors, leading to the development of processes that address the growing demand for effective radiopharmaceuticals in healthcare.

Conclusion

Maxim Y Kiselev’s contributions to the field of radiopharmaceuticals, particularly through his patented method for producing 2-fluoro-2-deoxyglucose, exemplify the importance of innovation in medical diagnostics. His work continues to influence the industry, showcasing the vital role of inventors in advancing healthcare technologies and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…